Indictment of Osteopathic Physician Signals Shift in Peptide Enforcement Stevens & Lee The peptide problem: Hype is outrunning the evidence Demand for Unapproved Weight Loss Drug Surges on Social Media MedPage Today The FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight loss results, Retatrutide